Alternative splicing of TCF7L2 gene in omental and subcutaneous adipose tissue and risk of type 2 diabetes

PLoS ONE

Volumn 4, Issue 9, 2009, Pages

  Prokunina Olsson, Ludmila ^a   Kaplan, Lee M ^b   Schadt, Eric E ^c   Collins, Francis S ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c PACIFIC BIOSCIENCES   (United States)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; TRANSCRIPTION FACTOR 7 LIKE 2; T CELL FACTOR PROTEIN; TCF7L2 TRANSCRIPTION FACTOR;

ADULT; ALTERNATIVE RNA SPLICING; ARTICLE; BIOPSY; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CONTROLLED STUDY; EXON; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; OBESITY; OMENTUM; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SUBCUTANEOUS FAT; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; BODY MASS; CASE CONTROL STUDY; GENETICS; GLYCOSYLATION; INTRON; METABOLISM; MIDDLE AGED; RISK;

ADULT; ALTERNATIVE SPLICING; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCOSYLATION; HUMANS; INTRONS; MALE; MIDDLE AGED; OBESITY; OMENTUM; RISK; SUBCUTANEOUS FAT; TCF TRANSCRIPTION FACTORS;

EID: 70349636577     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007231     Document Type: Article

References (27)

1. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, et al. (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38: 320-323.
2. Scott LJ, Bonnycastle LL, Willer CJ, Sprau AG, Jackson AU, et al. (2006) Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample. Diabetes 55: 2649-2653.
3. Saxena R, Gianniny L, Burtt NP, Lyssenko V, Giuducci C, et al. (2006) Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 55: 2890-2895.
4. Groves CJ, Zeggini E, Minton J, Frayling TM, Weedon MN, et al. (2006) Association analysis of 6,736 U.K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk. Diabetes 55: 2640-2644.
5. Reya T, Clevers H (2005) Wnt signalling in stem cells and cancer. Nature 434: 843-850.
6. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, et al. (1998) Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512.
7. Muncan V, Sansom OJ, Tertoolen L, Phesse TJ, Begthel H, et al. (2006) Rapid loss of intestinal crypts upon conditional deletion of the Wnt/ Tcf-4 target gene c-Myc. Mol Cell Biol 26: 8418-8426.
8. Tetsu O, McCormick F (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422-426.
9. Merrill BJ, Gat U, DasGupta R, Fuchs E (2001) Tcf3 and Lef1 regulate lineage differentiation of multipotent stem cells in skin. Genes Dev 15: 1688-1705.
10. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, et al. (2000) Inhibition of adipogenesis by Wnt signaling. Science 289: 950-953.
11. Miranda PJ, DeFronzo RA, Califf RM, Guyton JR (2005) Metabolic syndrome: definition, pathophysiology, and mechanisms. Am Heart J 149: 33-45.
12. Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, et al. (2006) TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 355: 241-250.
13. Cauchi S, Meyre D, Dina C, Choquet H, Samson C, et al. (2006) Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes. Diabetes 55: 2903-2908.
14. Cauchi S, Meyre D, Choquet H, Dina C, Born C, et al. (2006) TCF7L2 Variation Predicts Hyperglycemia Incidence in a French General Population: The Data From an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) Study. Diabetes 55: 3189-3192.
15. Cauchi S, Choquet H, Gutierrez-Aguilar R, Capel F, Grau K, et al. (2008) Effects of TCF7L2 polymorphisms on obesity in European populations. Obesity (Silver Spring) 16: 476-482.
16. Zhang W, Duan S, Bleibel WK, Wisel SA, Huang RS, et al. (2008) Identification of common genetic variants that account for transcript isoform variation between human populations. Hum Genet.
17. Graham RR, Kozyrev SV, Baechler EC, Reddy MV, Plenge RM, et al. (2006) A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 38: 550-555.
18. Elbein SC, Chu WS, Das SK, Yao-Borengasser A, Hasstedt SJ, et al. (2007) Transcription factor 7-like 2 polymorphisms and type 2 diabetes, glucose homeostasis traits and gene expression in US participants of European and African descent. Diabetologia 50: 1621-1630.
19. Lyssenko V, Lupi R, Marchetti P, Del Guerra S, Orho-Melander M, et al. (2007) Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 117: 2155-2163.
20. Osmark P, Hansson O, Jonsson A, Ronn T, Groop L, et al. (2009) Unique splicing pattern of the TCF7L2 gene in human pancreatic islets. Diabetologia.
21. Prokunina-Olsson L, Welch C, Hansson O, Adhikari N, Scott L, et al. (2009) Tissue-specific alternative splicing of TCF7L2. Hum Mol Genet.
22. http://hapmap.org/.
23. Zhong H, Beaulaurier J, Lum PY, Molony C, Yang X, et al. (2009) Elucidating Networks of eSNPs Associated with Type 2 Diabetes. PLOS Biology;in press.
24. Wegner L, Hussain MS, Pilgaard K, Hansen T, Pedersen O, et al. (2008) Impact of TCF7L2 rs7903146 on Insulin Secretion and Action in Young and Elderly Danish Twins. J Clin Endocrinol Metab.
25. Kovacs P, Berndt J, Ruschke K, Kloting N, Schon MR, et al. (2008) TCF7L2 gene expression in human visceral and subcutaneous adipose tissue is differentially regulated but not associated with type 2 diabetes mellitus. Metabolism 57: 1227-1231.
26. Fang M, Li J, Blauwkamp T, Bhambhani C, Campbell N, et al. (2006) C-terminal-binding protein directly activates and represses Wnt transcriptional targets in Drosophila. EMBO J 25: 2735-2745.
27. Thomas PD, Kejariwal A, Guo N, Mi H, Campbell MJ, et al. (2006) Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools. Nucleic Acids Res 34: W645-650.